Recent Advances in Rare Cancers: From Bench to Bedside and Back
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (20 December 2023) | Viewed by 368
Special Issue Editor
Interests: receptor tyrosine kinases; transcriptomics; clinical oncology, sarcoma, lung cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
About one in eight cancers diagnosed in adults belongs to the group of Rare Cancers, which by common definition occur at an annual incidence of less than 6 cases per 100,000 of the population. For comparison, the most common cancers in females and males, breast and prostate cancer, respectively, occur at a roughly 20-fold higher incidence than even the most ‘common’ of the Rare Cancers. This group encompasses a very large and heterogeneous range of cancers including carcinomas, sarcomas, and neuronal and hematologic malignancies. Increasing identification and definition of subtypes of these rare tumors fosters an understanding of their biologic dimensions. For instance, soft tissue sarcomas, a Rare Cancer occurring at an incidence of less than 5 per 100,00 of the population, may be subclassified into more than 70 subtypes with different biologies, clinical behaviors, and treatments. The downside of the identification of increasingly scarce subtypes of Rare Cancers is that classical clinical drug development via randomized clinical trials may become futile, owing to the impossibility of enrolling sufficient patient numbers.
This back-to-back Special Issue of Current Oncology provides a platform for latest research into Rare Cancers, showcasing new insights into their management.
You may choose our Joint Special Issue in Cancers.
Prof. Dr. Wolfgang Johannes Köstler
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rare cancers
- cancer subtypes
- pre-cancers
- esophageal cancer chronic myeloid leukemia
- childhood acute lymphoblastic leukemia
- anal cancer
- Merkel cell carcinoma
- thymic carcinoma
- hepatoblastoma
- sarcoma
- glioblastoma
- penile cancer
- salivary gland cancer
- small bowel adenocarcinoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
